Filing Details

Accession Number:
0000899243-21-017462
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-29 21:09:28
Reporting Period:
2021-04-27
Accepted Time:
2021-04-29 21:09:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI Surgical & Medical Instruments & Apparatus (3841) 471052611
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856367 A. Jaime Frias C/O Treace Medical Concepts, Inc.
203 Fort Wade Rd., Suite 150
Ponte Vedra FL 32081
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-27 85,570 $0.00 225,551 No 4 C Indirect Pensco Trust Company, LLC Custodian FBO Jaime A. Frias, IRA
Common Stock Acquisiton 2021-04-27 42,785 $0.00 372,016 No 4 C Direct
Common Stock Disposition 2021-04-27 329,230 $17.00 42,786 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Pensco Trust Company, LLC Custodian FBO Jaime A. Frias, IRA
No 4 C Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Acquisiton 2021-04-27 1,976 $0.00 1,976 $0.00
Common Stock Series A Preferred Stock Acquisiton 2021-04-27 988 $0.00 988 $0.00
Common Stock Series A Preferred Stock Disposition 2021-04-27 85,570 $0.00 85,570 $0.00
Common Stock Series A Preferred Stock Disposition 2021-04-27 42,785 $0.00 42,785 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
85,570 No 4 J Indirect
42,785 No 4 J Direct
0 No 4 C Indirect
0 No 4 C Direct
Footnotes
  1. Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The Shares had no expiration date.
  2. These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters.
  3. The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.